Phase 1/2a safety, tolerability, PK and PD study of AKCEA-APOCIII-LRx in healthy volunteers with elevated triglycerides (NCT0290027)

Please login or create a FREE account to view this content

Educational partners and supporters

Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc. Arrowhead Pharmaceuticals

Arrowhead Pharmaceuticals

Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc. Ionis Logo

Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc. Kowa Logo